Hugh O’neill
Executive Vice President President
pharmaceutical science
Mallinckrodt
Netherlands
Biography
Hugh O’Neill is executive vice president and president of autoimmune and rare diseases at Mallinckrodt Pharmaceuticals. He has executive responsibility and directly manages all commercialization efforts and broad market access activites for this portfolio within the company's Specialty Brands segment. Mr. O’Neill is a member of Mallinckrodt’s executive committee.
Research Interest
Pharmacogenomics & Pharmacoproteomics
